Diphtheria tetanus vaccine - Biological E

Drug Profile

Diphtheria tetanus vaccine - Biological E

Alternative Names: Adsorbed diphtheria and tetanus vaccine - Biological E; BE Td

Latest Information Update: 16 Jul 2014

Price : $50

At a glance

  • Originator Biological E Limited
  • Class Bacterial vaccines; Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Tetanus

Most Recent Events

  • 01 Aug 2013 Launched for Diphtheria and Tetanus (prevention, in adults, in adolescents) in India (IM)
  • 01 Jul 2013 Registered for Diphtheria and Tetanus (prevention, in adults, in adolescents) in India (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top